ConductScience.org, home

Paper40422249

All-Trans Retinoic Acid Induces Differentiation and Downregulates Stemness Markers and MGMT Expression in Glioblastoma Stem Cells.

Tang J and 1 other. Cells, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. All-Trans Retinoic Acid Induces Differentiation and Downregulates Stemness Markers and MGMT Expression in Glioblastoma Stem Cells. Papers, record 40422249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40422249

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
All-Trans Retinoic Acid Induces Differentiation and Downregulates Stemness Markers and MGMT Expression in Glioblastoma Stem Cells.
PubMed
Journal
Cells
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.54, provisional
iCite
Revised in PubMed
2025-05-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tang JJustin
2Yang RRaymond

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TretinoinMajor topic
GlioblastomaMajor topic
Neoplastic Stem CellsMajor topic
DNA Modification MethylasesMajor topic
Tumor Suppressor ProteinsMajor topic
Cell DifferentiationMajor topic
DNA Repair EnzymesMajor topic
Down-RegulationMajor topic
Biomarkers, TumorMajor topic
Brain NeoplasmsMajor topic
Humans
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Temozolomide

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110652267The coregulator exchange in transcriptional functions of nuclear receptors.Genes Dev2000https://conductscience.org/library/papers/10652267PubMed
21689217CNS stem cells express a new class of intermediate filament protein.Cell1990https://conductscience.org/library/papers/1689217PubMed
330352973DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid.Cancers (Basel)2018https://conductscience.org/library/papers/30352973PubMed
432429463Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer.Cells2020https://conductscience.org/library/papers/32429463PubMed
518948646SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.Stem Cells2009https://conductscience.org/library/papers/18948646PubMed
633123732CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.Neuro Oncol2020https://conductscience.org/library/papers/33123732PubMed
740277888Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance.Cells2025https://conductscience.org/library/papers/40277888PubMed
840214448Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions.Cells2025https://conductscience.org/library/papers/40214448PubMed
917485253MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.DNA Repair (Amst)2007https://conductscience.org/library/papers/17485253PubMed
1040075726The Complexity of Malignant Glioma Treatment.Cancers (Basel)2025https://conductscience.org/library/papers/40075726PubMed
1112697889Cost of migration: invasion of malignant gliomas and implications for treatment.J Clin Oncol2003https://conductscience.org/library/papers/12697889PubMed
1235626007Nuclear Receptor Coregulators in Hormone-Dependent Cancers.Cancers (Basel)2022https://conductscience.org/library/papers/35626007PubMed
1326109046Cancer stem cells in glioblastoma.Genes Dev2015https://conductscience.org/library/papers/26109046PubMed
1417051156Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.Nature2006https://conductscience.org/library/papers/17051156PubMed
1534298790Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide.Cancers (Basel)2021https://conductscience.org/library/papers/34298790PubMed
161382841Expression of the class VI intermediate filament nestin in human central nervous system tumors.Cancer Res1992https://conductscience.org/library/papers/1382841PubMed
1738002561Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings.Brain Sci2023https://conductscience.org/library/papers/38002561PubMed
1838928275Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ.Int J Mol Sci2024https://conductscience.org/library/papers/38928275PubMed
1939768176Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs.Cells2024https://conductscience.org/library/papers/39768176PubMed
2015207251Stem cell origin of cancer and differentiation therapy.Crit Rev Oncol Hematol2004https://conductscience.org/library/papers/15207251PubMed

See all 26 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42737697All-Trans Retinoic Acid and Curcumin Exhibit Hormesis or Synergistic Anticancer Effects in U87 Glioblastoma Cells: Defining the Proteome Accompanying Synergism.Int J Mol Sci2026https://conductscience.org/library/papers/42737697PubMed
42724852A single-center retrospective study evaluating the efficacy of anlotinib plus temozolomide for recurrent glioma based on real-world data.Transl Cancer Res2026https://conductscience.org/library/papers/42724852PubMed
42415956Multi-responsive tetrahedral DNA frameworks for in situ methyltransferase imaging to distinguish living chemoresistant tumor cells.Chem Sci2026https://conductscience.org/library/papers/42415956PubMed
42260303Molecular insights into DNA damage response plasticity in glioma stem cells.Commun Biol2026https://conductscience.org/library/papers/42260303PubMed
42065053MYO18A Expression is a Prognostic Factor for Progression-Free Survival in Grade 4 Adult gliomas. Preliminary Report.Oncol Res2026https://conductscience.org/library/papers/42065053PubMed
41898674Interleukin-2 and Tretinoin for Myeloproliferative Neoplasms and to Target Type 1 Calreticulin-Driven Neoplasms: Advancements in Immune Regenerative Medicine.Int J Mol Sci2026https://conductscience.org/library/papers/41898674PubMed
41347841Cancer stem cell heterogeneity‑inspired therapeutics for enhancing tumor treatment outcomes (Review).Int J Oncol2026https://conductscience.org/library/papers/41347841PubMed
41279756Spatial transcriptomics of glioblastoma defines biologically and clinically significant reprogramming patterns across unique spatial microenvironments.bioRxiv2025https://conductscience.org/library/papers/41279756PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACTB60PubTator's text mininghttps://conductscience.org/library/genes/60NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
MGMT4255PubTator's text mininghttps://conductscience.org/library/genes/4255NCBI Gene
NES10763PubTator's text mininghttps://conductscience.org/library/genes/10763NCBI Gene
SOX26657PubTator's text mininghttps://conductscience.org/library/genes/6657NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40422249

GET https://conductscience.org/api/papers/v1/40422249/references?page=2